|
Fundacion Publica Andaluza Para La Gestion De Investigacion En Salud De Sev
|
|
$100K
|
To carry out research into the underlying mechanism likely contributing to the pathogenesis of pulmonary complications in patients with autosomal dominant-hyper ige syndrome using ruxolitinib (jak - inhibitor to specifically target this pathway alteration).
|
2020
|
|
Boston Children's Hospital
|
Boston, MA
|
$100K
|
Investigating a non transcriptional role for il-stat3 in mitochondrial metabolism and ad-hies.
|
2020
|
|
Trustees of the University of Pennsylvania
|
Philadephia, PA
|
$100K
|
Carrying out research into using neutrophil-avid nanocarriers to treat the recurrent lung infections that are common in patients with job syndrome.
|
2020
|
|
University of Newcastle Upon Tyne
|
|
$100K
|
Carrying out research into the quality of life of patients with ad-hies, with particular focus on the impact of treatment on respiratory, dermatological and psychological health.
|
2020
|
|
The General Hospital Corporation Dba the Massachusetts General Hospital
|
Boston, MA
|
$100K
|
Carrying out research for the project entitled, "impaired epithelial differentiation and host defense as a mechanism for pulmonary complications in job syndrome patients".
|
2020
|
|
University of Nsw
|
|
$100K
|
Research into stat3-mediated regulation of the human immune response.
|
2020
|
|
The Rockefeller University
|
New York, NY
|
$100K
|
To fund the recipients research and operating budget.
|
2020
|
|
Klinikum Rechts Der Isar Der Technischen Universitat Munchen
|
|
$100K
|
To carry out research into fighting staphylococcus aureus infections at the mucosal surface in job syndrome.
|
2020
|
|
University of Newcastle Upon Tyne
|
|
$100K
|
Carrying out research into the quality of life of patients with ad-hies, with particular focus on the impact of treatment on respiratory, dermatological and psychological health.
|
2021
|
|
Trustees of the University of Pennsylvania
|
Philadelphia, PA
|
$100K
|
Carrying out research into using neutrophil-avid nanocarriers to treat the recurrent lung infections that are common in patients with job syndrome.
|
2021
|
|
The General Hospital Corporation Dba the Massachusetts General Hospital
|
Boston, MA
|
$100K
|
Carrying out research for the project entitled, "impaired epithelial differentiation and host defense as a mechanism for pulmonary complications in job syndrome patients".
|
2021
|
|
Boston Children's Hospital
|
Boston, MA
|
$100K
|
Investigating a non transcriptional role for il-stat3 in mitochondrial metabolism and ad-hies.
|
2021
|
|
Columbia University
|
New York, NY
|
$100K
|
To carry out research into the role of fiberoblast specific stat3 expression in pneumatocele development and gastrointestinal perforation in ad-hies
|
2021
|
|
Klinikum Rechts Der Isar Der Technischen Universitat Munchen
|
|
$100K
|
To carry out research into fighting staphylococcus aureus infections at the mucosal surface in job syndrome.
|
2021
|
|
Helmholtz Zentrum Munchen
|
|
$100K
|
Carrying out research into the evaluation of alveolar function, regeneration and gene repair in job syndrome
|
2023
|
|
Garvan Institute of Medical Research
|
|
$100K
|
Carrying out research into immune dysregulation in job syndrome- elucidating mechanisms of stat3- mediated host defense, humoral immunity and immune- mediated lung pathology
|
2023
|
|
Icahn School of Medicine at Mount Sinai
|
New York City, NY
|
$100K
|
Carrying out research into cross regulation of stat signaling pathways in lung pathology of experimental hies
|
2023
|
|
National Institute of Allergy and Infectious Diseases
|
Bethesda, MD
|
$100K
|
Carrying out research into the next-generation crispr base editing approaches to treat job syndrome.
|
2023
|
|
Helmholtz Zentrum Munchen
|
|
$100K
|
Carrying out research into the evaluation of alveolar function, regeneration and gene repair in job syndrome
|
2022
|
|
University of Freiburg
|
|
$100K
|
To carry out research for treating hyperigesyndrome by genome editing in cd34+ hematopoietic STEM and progenitor cells.
|
2022
|
|
University of Newcastle Upon Tyne
|
|
$100K
|
Carrying out research into the quality of life of patients with ad-hies, with particular focus on the impact of treatment on respiratory, dermatological and psychological health.
|
2022
|
|
National Institute of Allergy and Infectious Diseases
|
Bethesda, MD
|
$100K
|
Carrying out research into the next-generation crispr base editing approaches to treat job syndrome.
|
2022
|
|
Columbia University
|
New York, NY
|
$100K
|
To carry out research into the role of fiberoblast specific stat3 expression in pneumatocele development and gastrointestinal perforation in ad-hies
|
2022
|